Selected research
Industry Growth & Trends
Global Artificial Intelligence in Drug Discovery Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Artificial Intelligence in Drug Discovery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artificial Intelligence in Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Artificial Intelligence in Drug Discovery market include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Artificial Intelligence in Drug Discovery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Artificial Intelligence in Drug Discovery market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Intelligence in Drug Discovery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Intelligence in Drug Discovery.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Artificial Intelligence in Drug Discovery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Artificial Intelligence in Drug Discovery Market by Company
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc
Artificial Intelligence in Drug Discovery Segment by Type
Hardware
Software
Service
Artificial Intelligence in Drug Discovery Segment by Application
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
Artificial Intelligence in Drug Discovery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Drug Discovery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Artificial Intelligence in Drug Discovery companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software
- Service
Applications
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
Companies covered
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals, Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Artificial Intelligence in Drug Discovery Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Artificial Intelligence in Drug Discovery Market Size by Region (2021-2032)
- 1.4.1 Global Artificial Intelligence in Drug Discovery Market Size by Region (2021-2026)
- 1.4.2 Global Artificial Intelligence in Drug Discovery Market Size by Region (2027-2032)
- 1.5 Key Regions Artificial Intelligence in Drug Discovery Market Size (2021-2032)
- 1.5.1 North America Artificial Intelligence in Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Artificial Intelligence in Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.4 South America Artificial Intelligence in Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size Growth Rate (2021-2032)
2 Artificial Intelligence in Drug Discovery Market by Type
- 2.1 Type Introduction
- 2.1.1 Hardware
- 2.1.2 Software
- 2.1.3 Service
- 2.2 Global Artificial Intelligence in Drug Discovery Market Size by Type
- 2.2.1 Global Artificial Intelligence in Drug Discovery Market Size Overview by Type (2021-2032)
- 2.2.2 Global Artificial Intelligence in Drug Discovery Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Artificial Intelligence in Drug Discovery Market Size Forecasted by Type (2027-2032)
- 2.3 Global Artificial Intelligence in Drug Discovery Market Size by Regions
- 2.3.1 North America Artificial Intelligence in Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Artificial Intelligence in Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Artificial Intelligence in Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Artificial Intelligence in Drug Discovery Market Size Breakdown by Type (2021-2026)
3 Artificial Intelligence in Drug Discovery Market by Application
- 3.1 Type Introduction
- 3.1.1 Early Drug Discovery
- 3.1.2 Preclinical Phase
- 3.1.3 Clinical Phase
- 3.1.4 Regulatory Approval
- 3.2 Global Artificial Intelligence in Drug Discovery Market Size by Application
- 3.2.1 Global Artificial Intelligence in Drug Discovery Market Size Overview by Application (2021-2032)
- 3.2.2 Global Artificial Intelligence in Drug Discovery Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Artificial Intelligence in Drug Discovery Market Size Forecasted by Application (2027-2032)
- 3.3 Global Artificial Intelligence in Drug Discovery Market Size by Regions
- 3.3.1 North America Artificial Intelligence in Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Artificial Intelligence in Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Artificial Intelligence in Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Artificial Intelligence in Drug Discovery Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Artificial Intelligence in Drug Discovery Industry Trends
- 4.2 Artificial Intelligence in Drug Discovery Industry Drivers
- 4.3 Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges
- 4.4 Artificial Intelligence in Drug Discovery Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Artificial Intelligence in Drug Discovery Revenue (2021-2026)
- 5.2 Global Artificial Intelligence in Drug Discovery Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Artificial Intelligence in Drug Discovery Key Company Headquarters & Area Served
- 5.4 Global Artificial Intelligence in Drug Discovery Company, Product Type & Application
- 5.5 Global Artificial Intelligence in Drug Discovery Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Artificial Intelligence in Drug Discovery Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Artificial Intelligence in Drug Discovery Players Market Share by Revenue in 2025
- 5.6.3 2025 Artificial Intelligence in Drug Discovery Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 IBM
- 6.1.1 IBM Company Information
- 6.1.2 IBM Business Overview
- 6.1.3 IBM Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 IBM Artificial Intelligence in Drug Discovery Product Portfolio
- 6.1.5 IBM Recent Developments
- 6.2 Exscientia
- 6.2.1 Exscientia Company Information
- 6.2.2 Exscientia Business Overview
- 6.2.3 Exscientia Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Exscientia Artificial Intelligence in Drug Discovery Product Portfolio
- 6.2.5 Exscientia Recent Developments
- 6.3 Google(Alphabet)
- 6.3.1 Google(Alphabet) Company Information
- 6.3.2 Google(Alphabet) Business Overview
- 6.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio
- 6.3.5 Google(Alphabet) Recent Developments
- 6.4 Microsoft
- 6.4.1 Microsoft Company Information
- 6.4.2 Microsoft Business Overview
- 6.4.3 Microsoft Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Microsoft Artificial Intelligence in Drug Discovery Product Portfolio
- 6.4.5 Microsoft Recent Developments
- 6.5 Atomwise
- 6.5.1 Atomwise Company Information
- 6.5.2 Atomwise Business Overview
- 6.5.3 Atomwise Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Atomwise Artificial Intelligence in Drug Discovery Product Portfolio
- 6.5.5 Atomwise Recent Developments
- 6.6 Schrodinger
- 6.6.1 Schrodinger Company Information
- 6.6.2 Schrodinger Business Overview
- 6.6.3 Schrodinger Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio
- 6.6.5 Schrodinger Recent Developments
- 6.7 Aitia
- 6.7.1 Aitia Company Information
- 6.7.2 Aitia Business Overview
- 6.7.3 Aitia Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Aitia Artificial Intelligence in Drug Discovery Product Portfolio
- 6.7.5 Aitia Recent Developments
- 6.8 Insilico Medicine
- 6.8.1 Insilico Medicine Company Information
- 6.8.2 Insilico Medicine Business Overview
- 6.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio
- 6.8.5 Insilico Medicine Recent Developments
- 6.9 NVIDIA
- 6.9.1 NVIDIA Company Information
- 6.9.2 NVIDIA Business Overview
- 6.9.3 NVIDIA Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio
- 6.9.5 NVIDIA Recent Developments
- 6.10 XtalPi
- 6.10.1 XtalPi Company Information
- 6.10.2 XtalPi Business Overview
- 6.10.3 XtalPi Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 XtalPi Artificial Intelligence in Drug Discovery Product Portfolio
- 6.10.5 XtalPi Recent Developments
- 6.11 BPGbio
- 6.11.1 BPGbio Company Information
- 6.11.2 BPGbio Business Overview
- 6.11.3 BPGbio Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 BPGbio Artificial Intelligence in Drug Discovery Product Portfolio
- 6.11.5 BPGbio Recent Developments
- 6.12 Owkin
- 6.12.1 Owkin Company Information
- 6.12.2 Owkin Business Overview
- 6.12.3 Owkin Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Owkin Artificial Intelligence in Drug Discovery Product Portfolio
- 6.12.5 Owkin Recent Developments
- 6.13 CytoReason
- 6.13.1 CytoReason Company Information
- 6.13.2 CytoReason Business Overview
- 6.13.3 CytoReason Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 CytoReason Artificial Intelligence in Drug Discovery Product Portfolio
- 6.13.5 CytoReason Recent Developments
- 6.14 Deep Genomics
- 6.14.1 Deep Genomics Company Information
- 6.14.2 Deep Genomics Business Overview
- 6.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio
- 6.14.5 Deep Genomics Recent Developments
- 6.15 Cloud Pharmaceuticals
- 6.15.1 Cloud Pharmaceuticals Company Information
- 6.15.2 Cloud Pharmaceuticals Business Overview
- 6.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio
- 6.15.5 Cloud Pharmaceuticals Recent Developments
- 6.16 BenevolentAI
- 6.16.1 BenevolentAI Company Information
- 6.16.2 BenevolentAI Business Overview
- 6.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio
- 6.16.5 BenevolentAI Recent Developments
- 6.17 Cyclica
- 6.17.1 Cyclica Company Information
- 6.17.2 Cyclica Business Overview
- 6.17.3 Cyclica Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Cyclica Artificial Intelligence in Drug Discovery Product Portfolio
- 6.17.5 Cyclica Recent Developments
- 6.18 Verge Genomics
- 6.18.1 Verge Genomics Company Information
- 6.18.2 Verge Genomics Business Overview
- 6.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio
- 6.18.5 Verge Genomics Recent Developments
- 6.19 Valo Health
- 6.19.1 Valo Health Company Information
- 6.19.2 Valo Health Business Overview
- 6.19.3 Valo Health Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Valo Health Artificial Intelligence in Drug Discovery Product Portfolio
- 6.19.5 Valo Health Recent Developments
- 6.20 Envisagenics
- 6.20.1 Envisagenics Company Information
- 6.20.2 Envisagenics Business Overview
- 6.20.3 Envisagenics Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio
- 6.20.5 Envisagenics Recent Developments
- 6.21 Euretos
- 6.21.1 Euretos Company Information
- 6.21.2 Euretos Business Overview
- 6.21.3 Euretos Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Euretos Artificial Intelligence in Drug Discovery Product Portfolio
- 6.21.5 Euretos Recent Developments
- 6.22 BioAge Labs
- 6.22.1 BioAge Labs Company Information
- 6.22.2 BioAge Labs Business Overview
- 6.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio
- 6.22.5 BioAge Labs Recent Developments
- 6.23 Iktos
- 6.23.1 Iktos Company Information
- 6.23.2 Iktos Business Overview
- 6.23.3 Iktos Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Iktos Artificial Intelligence in Drug Discovery Product Portfolio
- 6.23.5 Iktos Recent Developments
- 6.24 BioSymetrics
- 6.24.1 BioSymetrics Company Information
- 6.24.2 BioSymetrics Business Overview
- 6.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio
- 6.24.5 BioSymetrics Recent Developments
- 6.25 Evaxion Biotech
- 6.25.1 Evaxion Biotech Company Information
- 6.25.2 Evaxion Biotech Business Overview
- 6.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio
- 6.25.5 Evaxion Biotech Recent Developments
- 6.26 Aria Pharmaceuticals, Inc
- 6.26.1 Aria Pharmaceuticals, Inc Company Information
- 6.26.2 Aria Pharmaceuticals, Inc Business Overview
- 6.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio
- 6.26.5 Aria Pharmaceuticals, Inc Recent Developments
7 North America
- 7.1 North America Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
- 7.3 North America Artificial Intelligence in Drug Discovery Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
- 8.3 Europe Artificial Intelligence in Drug Discovery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
- 10.3 South America Artificial Intelligence in Drug Discovery Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst